Provider Notice issued 03/28/11
PROVENGE®
| To: | Participating Advanced Practice Nurses, Hospitals, Pharmacies and Physicians |
| Date: | March 28, 2011 |
| Re: |
PROVENGE® |
The purpose of this notice is to inform providers that the department will not be providing coverage of PROVENGE® the new FDA approved immunotherapy for the treatment of prostate cancer.
Questions regarding this notice may be directed to the Bureau of Comprehensive Health Services at 1-877-782-5565.
Theresa A. Eagleson, Administrator
Division of Medical Programs